|
|
|
|
|
|
|
|
|
|
05.08.25 - 22:57
|
The Chemours Company Reports Second Quarter 2025 Results (Business Wire)
|
|
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quarter 2025.
Key Second Quarter 2025 Results & Highlights1
Net Sales of $1.6 billion, a 4% increase compared to the corresponding prior-year quarter, with TSS achieving year-over-year growth of 65% in Opteon™ Refrigerants
Net Loss attributable to Chemours of $381 million, or $2.54 per diluted share, compared with Net Income attributable to Chemours of $60 million, or $0.39 per diluted share, in the corresponding prior-year quarter
Adjusted Net Income2 of $87 million, or $0.58 per diluted share, compared to $58 million, or $0.38 per diluted share, in the corresponding prior-year quarter
Adjusted EBITDA2,3 of $253 million compared to $207 million in the corres...
|
|
|
|
|
29.07.25 - 22:33
|
Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call (Business Wire)
|
|
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025.
The Company expects to hold its conference call to discuss its second quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com.
Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides.
Replay: A webcast replay will be available at investors.chemours.com.
About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industri...
|
|
|
|
06.07.25 - 15:15
|
UBS Finds "Chilling Opportunity" In Data Center Cooling (ZeroHedge)
|
|
UBS Finds "Chilling Opportunity" In Data Center Cooling
As artificial intelligence chips become more powerful and energy-intensive, legacy air-based cooling systems are fast approaching obsolescence. Chemours is addressing this gap with its next-generation 2-phase liquid cooling technologies, which UBS describes as "purpose-built for more demanding applications in data centers." With thermal loads projected to exceed 200 to 1,000 kW per rack by the end of the decade, advanced cooling is no longer optional. UBS, calling it a "chilling opportunity," sees Chemours well-positioned to lead this transition.
A team of analysts led by Joshua Spector stated that Chemours is commercializing two proprietary 2-phase coolant solutions — Opteon SF33 for direct-to-chip cooling and Opteon 2P50 for immersion cooling — aimed at cooling next-generation AI data centers operating at high kW per rack.
What is Chemours doing with data centers?
Spector noted:
Chemours has devel...
|
|
|
|
12.06.25 - 22:33
|
Chemours Appoints Matthew Conti as Chief Human Resources Officer (Business Wire)
|
|
Seasoned HR executive supports Chemours' Pathway to Thrive strategyWILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy.
In this role, Conti will lead Chemours' global human resources organization, overseeing talent strategy, organizational development, employee engagement, and culture initiatives. He will play a pivotal role in advancing the company's Pathway to Thrive strategy by aligning human capital priorities with business objectives and fostering a high-performing culture.
“Matthew's appointment comes at a critical time as we continue to evolve our culture and capa...
|
|